PPARA and nonpapillary renal cell carcinoma: There were a few limitations in our study: (i) we did not perform in vivo experiments to support our in vitro results, and (ii) the measurement of FAO activity and lipid storage would further support the potential metabolic shift induced by miR-21 silencing and/or PPAR-α activation in ccRCC.